Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix - A Gynecologic Oncology Group study

William P. McGuire, John A. Blessing, Kenneth D. Hatch, Michael L. Berman

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix - A Gynecologic Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences